{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-138321","form_type":"8-K","ticker":null,"cik":"0001492674","company_name":"T2 Biosystems, Inc.","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.643731+00:00","generated_at":"2026-06-02T00:42:07.143662+00:00","sec_items":["5.03"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"T2 Biosystems amendments enable CRG debt-to-equity conversion; CRG now owns 69%","bullets":["Removed beneficial ownership limitations on Series A and B Preferred Stock on May 9, 2024.","CRG converted all preferred shares into 1,824,800 common shares, raising its ownership to ~69%.","This follows prior conversions of $15M (May 2024) and $10M (July 2023) debt from CRG into equity.","As a result, CRG now holds a controlling stake, significantly diluting other shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-138321","json":"https://secwatch.observer/filing/0001193125-24-138321.json","markdown":"https://secwatch.observer/filing/0001193125-24-138321.md","text":"https://secwatch.observer/filing/0001193125-24-138321.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1492674/000119312524138321/0001193125-24-138321-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1492674/000119312524138321/d836013d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T00:42:07.143662+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"352ed5349b809942c5745ca67987b75b3ac58a1d","claim":"T2 Biosystems, Inc.: Amended and restated the Series A and Series B Certificates of Designation to remove beneficial ownership limitations on conversion of preferred stock into common stock (effective 2024-05-09).","evidence_excerpt":"On May 9, 2024, the Company amended and restated each of the Series A Certificate of Designation and the Series B Certificate of Designation, in each case to remove the beneficial ownership limitations regarding the ability to convert the Series A Preferred Stock and Series B Preferred Stock, respectively, into shares of Common Stock without regarding to the beneficial ownership of the shareholder following such conversion.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1492674/000119312524138321/0001193125-24-138321-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-05-09"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}